Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
© NHSBT

Radcliffe Department of Medicine's Professor David Roberts, who is also Associate Medical Director, NHS Blood and Transplant, is co-leading an NHS Blood and Transplant programme to collect convalescent plasma from people who have recovered from COVID-19 to support a national clinical trial. The UK Department of Health and Social Care announced the programme on Saturday 25 April.

Professor Hugh Watkins, who heads the Radcliffe Department of Medicine said “We are keen to bring the expertise and facilities we have here at the department to help solve what is likely to be the greatest public health crisis of our generation.”

“Transfusion of antibody-containing plasma from recovered patients has been an effective treatment strategy for other viral diseases, so this is an important trial.”

The transfusions will be done through the existing REMAP-CAP trial and further trial options are being explored.

Read more on the Radcliffe Department of Medicine website

Read more about the trial on the NHS Blood and Transplant website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.